Form 4: QuidelOrtho Director James Prutow Reports Acquisition of Restricted Stock Units

Director James Prutow reports the acquisition of restricted stock units in QuidelOrtho Corp.

Summary

• On May 22, 2024, James Prutow, a director of QuidelOrtho Corp, acquired restricted stock units (RSUs) representing the right to receive common stock.
• Prutow acquired 4,929 RSUs, which will vest on May 22, 2025.
• He also acquired 1,760 RSUs and 352 RSUs in lieu of cash payments for retainer and Board of Director service-related fees under a deferred compensation program.
• 440 of the 1,760 shares vested on May 22, 2024, with the remaining vesting in three equal installments on August 22, 2024, November 22, 2024, and February 22, 2025.
• Following these transactions, Prutow directly owns 4,929 + 1,760 + 352 = 7,041 RSUs.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions by a company director. The acquisition of shares can be seen as a positive sign, but it's not a major event.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's financial performance or strategic direction, but the vesting schedule of the RSUs indicates a multi-year horizon.

Industry Context

This filing is a routine disclosure related to insider transactions and doesn't provide specific insights into QuidelOrtho's competitive positioning or broader industry trends. However, equity grants are a common practice in the industry to align management's interests with those of shareholders.

Stakeholder Impact

• The acquisition of RSUs by a director can have a slightly positive impact on shareholder sentiment.

Key Dates